» Articles » PMID: 34772801

Improved RAD51 Binders Through Motif Shuffling Based on the Modularity of BRC Repeats

Overview
Specialty Science
Date 2021 Nov 13
PMID 34772801
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Exchanges of protein sequence modules support leaps in function unavailable through point mutations during evolution. Here we study the role of the two RAD51-interacting modules within the eight binding BRC repeats of BRCA2. We created 64 chimeric repeats by shuffling these modules and measured their binding to RAD51. We found that certain shuffled module combinations were stronger binders than any of the module combinations in the natural repeats. Surprisingly, the contribution from the two modules was poorly correlated with affinities of natural repeats, with a weak BRC8 repeat containing the most effective N-terminal module. The binding of the strongest chimera, BRC8-2, to RAD51 was improved by -2.4 kCal/mol compared to the strongest natural repeat, BRC4. A crystal structure of RAD51:BRC8-2 complex shows an improved interface fit and an extended β-hairpin in this repeat. BRC8-2 was shown to function in human cells, preventing the formation of nuclear RAD51 foci after ionizing radiation.

Citing Articles

DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces.

Miron S, Legrand P, Dupaigne P, van Rossum-Fikkert S, Ristic D, Majeed A Nucleic Acids Res. 2024; 52(12):7337-7353.

PMID: 38828772 PMC: 11229353. DOI: 10.1093/nar/gkae452.


Novel COVID-19 biomarkers identified through multi-omics data analysis: N-acetyl-4-O-acetylneuraminic acid, N-acetyl-L-alanine, N-acetyltriptophan, palmitoylcarnitine, and glycerol 1-myristate.

Cobre A, Alves A, Gotine A, Domingues K, Lazo R, Ferreira L Intern Emerg Med. 2024; 19(5):1439-1458.

PMID: 38416303 DOI: 10.1007/s11739-024-03547-1.


A recombinant approach for stapled peptide discovery yields inhibitors of the RAD51 recombinase.

Pantelejevs T, Zuazua-Villar P, Koczy O, Counsell A, Walsh S, Robertson N Chem Sci. 2023; 14(47):13915-13923.

PMID: 38075664 PMC: 10699557. DOI: 10.1039/d3sc03331g.


Ultrahigh-Throughput Enzyme Engineering and Discovery in Compartments.

Gantz M, Neun S, Medcalf E, van Vliet L, Hollfelder F Chem Rev. 2023; 123(9):5571-5611.

PMID: 37126602 PMC: 10176489. DOI: 10.1021/acs.chemrev.2c00910.


Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications.

Cai D, Hou B, Xie S Amino Acids. 2023; 55(5):563-578.

PMID: 37067568 DOI: 10.1007/s00726-023-03255-8.


References
1.
Scott D, Coyne A, Venkitaraman A, Blundell T, Abell C, Hyvonen M . Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases. ChemMedChem. 2014; 10(2):296-303. PMC: 4506530. DOI: 10.1002/cmdc.201402428. View

2.
Ernst P, Zosel F, Reichen C, Nettels D, Schuler B, Pluckthun A . Structure-Guided Design of a Peptide Lock for Modular Peptide Binders. ACS Chem Biol. 2020; 15(2):457-468. DOI: 10.1021/acschembio.9b00928. View

3.
Scott D, Marsh M, Blundell T, Abell C, Hyvonen M . Structure-activity relationship of the peptide binding-motif mediating the BRCA2:RAD51 protein-protein interaction. FEBS Lett. 2016; 590(8):1094-102. PMC: 4855620. DOI: 10.1002/1873-3468.12139. View

4.
Isakov N, Wange R, Burgess W, Watts J, Aebersold R, Samelson L . ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity. J Exp Med. 1995; 181(1):375-80. PMC: 2191847. DOI: 10.1084/jem.181.1.375. View

5.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View